Candel reports extended survival in lung cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. USO
7. LAES
8. FUL
9. AAPL
10. IBM

Go back to Candel reports extended survival in lung cancer trial
(NASDAQ: CADL) Delayed: 9.37 +0.10 (1.08%)
Previous Close $9.27    52 Week High $ 
Open $9.24    52 Week Low $ 
Day High $9.61    P/E N/A 
Day Low $9.06    EPS $ 
Volume 891,609